EMA Waves Goodbye To HTA Network As Collaboration Framework Enters New Phase
A report published by the European Medicines Agency highlights milestones reached under its collaboration with EUnetHTA over recent years and outlines areas for further development once the initiative changes hands under the new HTA Regulation.
You may also be interested in...
EUnetHTA 21, the EU health technology assessment network that will soon hang up its hat has defended the methodologies it developed to support the EU HTA Regulation in the wake of criticism from industry.
A bigger role for companies in the scoping process for the imminent EU-level joint clinical assessments is essential for patient access, according to industry.
A new format for obtaining parallel scientific advice from the European Medicines Agency and national health technology assessment bodies in Europe is coming soon.